It is known that PGC-1α induces utrophin expression, a protein homologous to dystrophin in dystrophic muscles, which compensates for its absence, being a promising strategy for the treatment of DMD [42,43]. The gene discussed is UTRN; the disease is Duchenne muscular dystrophy.